Immunome (IMNM) Shares Outstanding: 2023-2025
Historic Shares Outstanding for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $91.7 million.
- Immunome's Shares Outstanding rose 51.78% to $91.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.7 million, marking a year-over-year increase of 51.78%. This contributed to the annual value of $64.5 million for FY2024, which is 49.04% up from last year.
- Immunome's Shares Outstanding amounted to $91.7 million in Q3 2025, which was up 5.39% from $87.0 million recorded in Q2 2025.
- Over the past 5 years, Immunome's Shares Outstanding peaked at $91.7 million during Q3 2025, and registered a low of $12.2 million during Q1 2023.
- In the last 3 years, Immunome's Shares Outstanding had a median value of $60.0 million in 2024 and averaged $53.6 million.
- Data for Immunome's Shares Outstanding shows a peak YoY skyrocketed of 395.16% (in 2024) over the last 5 years.
- Over the past 3 years, Immunome's Shares Outstanding (Quarterly) stood at $43.3 million in 2023, then surged by 49.04% to $64.5 million in 2024, then spiked by 51.78% to $91.7 million in 2025.
- Its Shares Outstanding stands at $91.7 million for Q3 2025, versus $87.0 million for Q2 2025 and $87.0 million for Q1 2025.